NeoGenomics Inc

Stock Chart, Company Information, and Scan Results

$10.10(as of Nov 4, 3:59 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

NeoGenomics Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$10.10
Ticker SymbolNEO
ExchangeNasdaq
SectorHealthcare
IndustryDiagnostics & Research
Employees2,200
CountyUSA
Market Cap$1,265.4M
EBIDTA-14.5M
10-Day Moving Average10.12
P/E Ratio-2.28
20-Day Moving Average9.92
Forward P/E Ratio222.22
50-Day Moving Average8.86
Earnings per Share-0.89
200-Day Moving Average8.84
Profit Margin-14.45%
RSI58.06
Shares Outstanding129.4M
ATR0.55
52-Week High19.12
Volume3,063,139
52-Week Low4.72
Most Recent Support Level9.42
Book Value936.2M
Most Recent Resistance Level10.58
P/B Ratio0.28
Upper Keltner11.16
P/S Ratio0.36
Lower Keltner8.68
Debt-to-Equity Ratio11.16
Next Earnings Date11/11/2025
Cash Surplus66.3M
Next Ex-Dividend DateUnknown

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through two segments: Clinical Services and Advanced Diagnostics. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company offers molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.

NeoGenomics Inc In Our Stock Scanner

As of Nov 05, 2025
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Increasing Book ValueScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Low PB RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Low PS RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Golden CrossScan Type: Stock Indicator Scans
As of ---
example chart graphic
Scan Name: Increasing Profit MarginScan Type: Stock Fundamentals
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.